Therapeutic concept

• Active hyperthermia ("A healthy fever")
• Mild/moderate whole-body hyperthermia
• Loco-regional electro-hyperthermia
• Local chemofusion/embolisation
• Galvanotherapy
• Microcurrent

Supportive therapy

• Pain therapy/pain management with infusion pumps
• Nutrition medicine/tumour metabolism-adapted nutrition concepts
• Orthomolecular therapy
• Immunotherapy
• Phytotherapie/Homöopathie
• Psychooncology
• Location-independent mobile therapy concepts

Ruhr-Universität Bochum
Institut für Hyperthermie- u.
Ernährungsforschung
Dr. med. Hüseyin Sahinbas

Clinical events

Extensive clinical tests have been made on the different methods of hyperthermia in combination with radiotherapy and/or chemotherapy. In general, the combination enables a clinically significant improvement of therapeutic efficiency.

Whole-boy hyperthermia:
There are studies available to evidence the feasibility of the method, giving reason to expect a better response, especially with respect to therapy-refractory and resistant illnesses.

Indications for whole-body hyperthermia:
Die Hyperhermie hat ein weites Indikations­spektrum für therapie­resistente Krankheiten. Z.B.:

• Cancer

• Rheumatic illnesses

• Chron. backache - ischialgia

• Fibromyalgie (s. RCT-Studie 2007)

• Arthrosis

• Neuralgia

• Asthma bronchiale

• Neurodermitis

• Migraine

• Arterial hypertension

• Bechterew's disease

• and many more

Local hyperthermia:
Research shows coinciding and clearly higher rates of complete remission in the combination of radiotherapy with hyperthermia in comparison to the sole application of radiotherapy. The addition of hyperthermia to radiotherapy or chemotherapy was tested in more than 28 randomised, controlled clinical studies. 21 studies showed significantly better results from the combination with hyperthermia.

Especially in the treatment of patients with primary, high-grade malignant brain tumours at our institute (glioma WHO grade III and IV) we achieved complete and long-lasting partial remission rates with advanced, therapy-resistant patients, which are very promising and clearly superior to former methods.